WeVote
Log In

Bill

Bill

S 7641

Designates revenue collected by the opioid excise tax for the New York state drug treatment and public education fund

2025 Regular Session Introduced by Cordell Cleare and 1 co-sponsor

Earmarks all opioid excise tax revenue to the New York drug treatment and public education fund, creating a dedicated funding stream for treatment programs and opioid education.

REFERRED TO BUDGET AND REVENUE
0
WeVote Research Nonpartisan
Bill Summary · S 7641

Summary of Senate Bill S 7641

Title

Designates revenue collected by the opioid excise tax for the New York state drug treatment and public education fund

Sponsor

  • Primary sponsor: Nathalia Fernandez

Status and History

  • Introduced: April 24, 2025
  • Current status: REFERRED TO BUDGET AND REVENUE
  • Legislative actions: Referred to Budget and Revenue on 2025-04-24 (listed twice in the record)

Purpose and Intent

  • The bill designates all revenue collected from the opioid excise tax to be deposited into (and used by) the New York state drug treatment and public education fund. The aim is to create a dedicated funding stream to support drug treatment services and public education initiatives related to opioids.

Key Provisions (as implied by the title and summary)

  • Creates/allocates a dedicated funding stream: Opioid excise tax revenue would be earmarked for the New York state drug treatment and public education fund.
  • Establishes a dedicated fund: The designated revenues would support the fund intended for drug treatment programs and related public education activities.
  • Governing rules: The bill would implement the mechanism by which opioid excise tax receipts are deposited into the fund and may establish basic governance/administrative provisions (e.g., reception, accounting, and reporting) as defined in the bill text.
  • Allocation and usage: The bill would specify that the designated funds are used for drug treatment services and public education, though exact allocation formulas, eligible programs, and administrative oversight would be detailed in the bill's full text.

Funding and Financial Impact

  • Revenue earmark: Reallocates opioid excise tax receipts from potential general fund use to a specialized fund.
  • Fiscal implications: If enacted, the state would have a dedicated funding source for drug treatment and opioid-related public education, potentially altering general fund budgeting and appropriations. Specific dollar amounts, caps, or annual growth assumptions would be defined in the statute language.

Affected Parties and Stakeholders

  • Taxpayers who pay the opioid excise tax (income in which the tax is embedded).
  • State agencies administering opioid policy, revenue collection, and grants (e.g., Department of Taxation and Finance; agencies overseeing drug treatment and public education programs).
  • Providers and organizations delivering drug treatment services.
  • Public health and education programs focused on opioid awareness and prevention.

Procedural and Timeline Notes

  • The bill is in early committee stage (Budget and Revenue). No enactment date is provided in the available information.
  • The text and any effective date, sunset provisions, or transition timelines would be established in the bill's full language.

Observations

  • The summary here is based on the bill title and status provided. For precise provisions (e.g., exact designation rules, fund governance, reporting requirements, and effective date), the complete bill text in its final form should be consulted.

If you’d like, I can tailor this further to compare with current NY law on opioid revenues or draft a one-page explainer for constituents.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.